Jump to content

Kebuzone

From Wikipedia, the free encyclopedia
Kebuzone
Clinical data
Routes of
administration
intramuscular
ATC code
Pharmacokineticdata
Eliminationhalf-life70–100 hours
Excretionrenal
Identifiers
  • 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
CompTox Dashboard(EPA)
ECHA InfoCard100.011.560Edit this at Wikidata
Chemical and physical data
FormulaC19H18N2O3
Molar mass322.364g·mol−1
3D model (JSmol)
  • CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
  • InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3☒N
  • Key:LGYTZKPVOAIUKX-UHFFFAOYSA-N☒N
☒NcheckY(what is this?)(verify)

Kebuzone(orketophenylbutazone) is anonsteroidal anti-inflammatory drug(NSAID) that is used for the treatment of inflammatory conditions such asthrombophlebitisandrheumatoid arthritis(RA).[1][2][3]

References

[edit]
  1. ^Austria-Codex(in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
  2. ^"KEBUZONE".NCATS Inxight: Drugs.Retrieved2019-02-27.
  3. ^Aronson JK (2016)."Kebuzone".Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions(Sixteenth ed.). Amsterdam. p. 405.ISBN978-0-444-53716-4.{{cite book}}:CS1 maint: location missing publisher (link)